Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vose

Showing results (621-630 of 891) with videos related to

Pageof 90
Sort By:
Clinical Lymphoma, Myeloma & Leukemia|August 27, 2017
Rituximab Improves the Outcome of Patients With Grade 3 Follicular Lymphoma Receiving Anthracycline-Based TherapyJi Yuan, Timothy C Greiner, Kai Fu, et al.
Cancer Genetics and Cytogenetics|January 11, 2007
Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletionAvadhut D Joshi, John D Dickinson, Ganapati V Hegde, et al.
Plos One|February 22, 2014
A biophysical basis for mucus solids concentration as a candidate biomarker for airways diseaseDavid B Hill, Paula A Vasquez, John Mellnik, et al.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|February 9, 2002
Combination therapy for non-Hodgkin's lymphoma: an opportunity for pharmaceutical care in a specialty practiceSamuel C Augustine, Jeffrey P Norenberg, David M Colcher, et al.
Leukemia Research|March 21, 2006
Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's diseaseMaher Albitar, Julie M Vose, Marcella M Johnson, et al.
Blood|December 1, 1992
Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescentsB G Gordon, P I Warkentin, D D Weisenburger, et al.
Bone Marrow Transplantation|December 11, 2012
Factors affecting the development of atrial fibrillation and atrial flutter (AF/AFL) following autologous hematopoietic SCT (auto-HSCT)J A Steuter, M L H Villanueva, F R Loberiza, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 19, 2013
Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?Nicholas A Barber, Fausto R Loberiza, Anamarija M Perry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual diseaseJulie M Vose, Graham Sharp, Wing C Chan, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1983
Propantheline bromide plasma level, urinary excretion and pharmacological data in a comparison of the bioavailability of three oral formulations of Pro-BanthineG V Rigby, C W Vose, N J Haskins, et al.
Pageof 90

Showing results (621-630 of 891) with videos related to

Sort By:
Pageof 90
Clinical Lymphoma, Myeloma & Leukemia|August 27, 2017
Rituximab Improves the Outcome of Patients With Grade 3 Follicular Lymphoma Receiving Anthracycline-Based TherapyJi Yuan, Timothy C Greiner, Kai Fu, et al.
Cancer Genetics and Cytogenetics|January 11, 2007
Bulky lymphadenopathy with poor clinical outcome is associated with ATM downregulation in B-cell chronic lymphocytic leukemia patients irrespective of 11q23 deletionAvadhut D Joshi, John D Dickinson, Ganapati V Hegde, et al.
Plos One|February 22, 2014
A biophysical basis for mucus solids concentration as a candidate biomarker for airways diseaseDavid B Hill, Paula A Vasquez, John Mellnik, et al.
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|February 9, 2002
Combination therapy for non-Hodgkin's lymphoma: an opportunity for pharmaceutical care in a specialty practiceSamuel C Augustine, Jeffrey P Norenberg, David M Colcher, et al.
Leukemia Research|March 21, 2006
Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's diseaseMaher Albitar, Julie M Vose, Marcella M Johnson, et al.
Blood|December 1, 1992
Bone marrow transplantation for peripheral T-cell lymphoma in children and adolescentsB G Gordon, P I Warkentin, D D Weisenburger, et al.
Bone Marrow Transplantation|December 11, 2012
Factors affecting the development of atrial fibrillation and atrial flutter (AF/AFL) following autologous hematopoietic SCT (auto-HSCT)J A Steuter, M L H Villanueva, F R Loberiza, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 19, 2013
Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?Nicholas A Barber, Fausto R Loberiza, Anamarija M Perry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2002
Autologous transplantation for aggressive non-Hodgkin's lymphoma: results of a randomized trial evaluating graft source and minimal residual diseaseJulie M Vose, Graham Sharp, Wing C Chan, et al.
European Journal of Drug Metabolism and Pharmacokinetics|July 1, 1983
Propantheline bromide plasma level, urinary excretion and pharmacological data in a comparison of the bioavailability of three oral formulations of Pro-BanthineG V Rigby, C W Vose, N J Haskins, et al.
Pageof 90